查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
太空生物学市场 - 全球和区域分析：按分子技术、产品类型、样本类型、应用和区域进行的分析和预测（2025-2035 年）
市场调查报告书
商品编码
1836231

太空生物学市场 - 全球和区域分析：按分子技术、产品类型、样本类型、应用和区域进行的分析和预测（2025-2035 年）

Spatial Biology Market - A Global and Regional Analysis: Focus on Molecular Technology, Product Type, Sample Type, Application, and Regional Analysis - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 159 Pages | 商品交期: 1-5个工作天内

价格

空间生物学是一个新兴的科学领域，探索细胞、分子和生物过程在其原生组织环境中如何排列和相互作用。

整合空间转录组学、蛋白质组学、代谢体学、多体学和高解析度成像等技术，使我们能够可视化组织内基因、蛋白质和其他分子的精确位置和活性。了解这种空间背景有助于更深入地理解细胞功能、细胞间通讯和疾病进展机制，从而为癌症、神经科学和免疫学等领域提供新的见解。这些方法正在揭示疾病机制和细胞间相互作用的新维度，为更精准的诊断、标靶治疗和个人化医疗铺平道路。

主要市场统计数据
预测期 2025-2035
2025年评估 18.937亿美元
2035年预测 63.911亿美元
复合年增长率 13.1%

市场概况

全球太空生物市场预计未来将大幅成长，到2035年将达到63.911亿美元。

空间生物学正在成为生命科学领域一门变革性学科，使研究人员能够研究细胞、分子和生物过程在其原生组织环境中的排列和相互作用。透过将空间转录组学、蛋白质组学、代谢体学以及高度体学的整合多组学技术与先进的成像技术相结合，空间生物学为疾病机制、细胞相互作用和组织结构提供了前所未有的洞察。这些能力正在推动癌症研究、神经科学、免疫学和精准医疗等领域的突破性发现，使太空生物学成为下一代诊断和治疗的关键驱动力。

空间转录组学/基因组学处于领先地位，到 2024 年将占据 41.15% 的市场份额，预计在 2025 年至 2035 年的预测期内将以 13.52% 的复合年增长率扩张。

空间转录组学/基因组学技术作为一种创新方法，可以在空间背景下可视化组织内的基因表现模式，正在推动市场成长。该技术将 RNA定序与空间条码、原位杂合反应和高解析度显微镜相结合，以细胞分辨率创建组织分子图。其应用正在肿瘤学、神经科学和发育生物学等领域迅速扩展，研究人员正在使用这项技术来更好地了解组织异质性、细胞间相互作用和疾病机制。此外，10x Genomics 和 NanoString Technologies 等公司提供的易于使用的平台的广泛可用性，以及人们对空间分辨多组体学研究日益增长的兴趣，正在加速其应用。在对精准医疗和标靶治疗的需求不断增长的背景下，空间转录组学预计将在塑造分子诊断和药物发现的未来方面发挥核心作用，为全球太空生物学市场的整体扩张做出重大贡献。

依产品类型划分，至2024年，耗材领域将以41.64%的市占率主导市场。耗材是支撑稳定经常性收益和技术创新的核心组成部分。它们对于RNA、蛋白质和代谢物等分子标靶的内部製备、标记和检测至关重要，而这些标靶构成了空间分析工作流程的基础。 10x Genomics、NanoString Technologies和Akoya Biosciences等主要企业已推出专注于各自空间平台的耗材产品线。

本报告研究了全球空间生物学市场，并总结了主要趋势、市场影响因素分析、法律规范、市场规模趋势和预测、各个细分市场和主要国家的详细分析、竞争格局以及主要企业的概况。

目录

执行摘要

范围和定义

第一章市场：产业展望

  • 主要市场趋势
    • 影响分析
  • 对高通量和发现主导平台的需求激增
  • 向抗体独立的空间体学技术过渡
  • 法律规范
    • 美国
    • EU
    • 日本
    • 中国
  • 供应链分析
  • 市场动态
    • 市场驱动因素
    • 市场限制
    • 市场机会

第二章 透过分子技术

  • 透过分子技术
    • 概述
  • 空间转录组学/基因组学
    • 基于定序的空间转录组学
    • 原位杂合反应（ISH）
    • 原位定序（ISS）
    • 其他的
  • 空间蛋白质体学
    • 基于抗体的多重影像
    • MALDI-MS成像
    • 原位定序（CITE-seq）
    • 深度可视化蛋白质体学（DVP）
    • 其他的
  • 空间代谢代谢体学
    • MALDI质谱成像（MALDI-MSI）
    • 解吸电洒电离（DESI）和奈米DESI成像
  • 空间体学
  • 其他的

第三章 副产品

  • 按产品
    • 概述
    • 耗材
    • 设备/平台
    • 服务

第四章 样本类型

  • 依样本类型
    • 概述
    • 福马林固定石蜡包埋（FFPE）
    • 新鲜冷冻组织
    • 固定冷冻组织

第五章 按用途

  • 按用途
    • 概述
    • 癌症研究
    • 免疫学和感染疾病
    • 神经科学
    • 其他的

第 6 章 按最终用户

  • 按最终用户
    • 概述
    • 製药和生物技术公司
    • 学术研究机构
    • 受託研究机构（CRO）
    • 医院

第七章 区域

  • 区域摘要
  • 北美洲
    • 区域概况
    • 市场成长动力
    • 市场问题
    • 分析师观点
    • 美国
    • 加拿大
  • 欧洲
    • 区域概况
    • 市场成长动力
    • 市场问题
    • 分析师观点
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 其他的
  • 亚太地区
    • 区域概况
    • 市场成长动力
    • 市场问题
    • 分析师观点
    • 中国
    • 日本
    • 印度
    • 新加坡
    • 澳洲
    • 其他的
  • 拉丁美洲
    • 区域概况
    • 市场成长动力
    • 市场问题
    • 分析师观点
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 区域概况
    • 市场成长动力
    • 市场问题
    • 分析师观点
    • 埃及
    • 沙乌地阿拉伯
    • 其他的

第八章市场：竞争基准化分析与公司简介

  • Akoya Biosciences, Inc.
  • 10x Genomics
  • Standard BioTools
  • Bio-Techne
  • Illumina, Inc.
  • Bruker Corporation
  • Flagship Biosciences, Inc.
  • S2 Genomics, Inc.
  • MGI Tech Co., Ltd.
  • Vizgen Inc.
  • RareCyte, Inc.
  • Miltenyi Biotec
  • Spatial Genomics
  • Singular Genomics
  • Stellaromics

第九章调查方法

Product Code: BHL3324SA

This report can be delivered within 1 working day.

Introduction of Spatial biology

Spatial biology is an advanced scientific discipline that explores how cells, molecules, and biological processes are organized and interact within their native tissue environments. By integrating techniques such as spatial transcriptomics, proteomics, metabolomics, multi-omics, and high-resolution imaging, it enables researchers to visualize the precise location and activity of genes, proteins, and other analytes across tissues. This spatial context provides a deeper understanding of cellular function, communication, and disease progression, uncovering new insights in areas such as cancer, neuroscience, and immunology. Collectively, these approaches are unlocking new dimensions in understanding disease mechanisms and cellular interactions, paving the way for more precise diagnostics, targeted therapies, and personalized medicine.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$1,893.7 Million
2035 Forecast$6,391.1 Million
CAGR13.1%

Market Introduction

The global Spatial biology market is expected to witness significant expansion, projected to reach $6,391.1 million by 2035.

Spatial biology is emerging as a transformative discipline in life sciences, enabling researchers to study how cells, molecules, and biological processes are organized and interact within their native tissue environments. By combining spatial transcriptomics, proteomics, metabolomics, and high-plex multi-omics integration with advanced imaging, spatial biology provides unprecedented insights into disease mechanisms, cellular interactions, and tissue architecture. These capabilities are fueling breakthroughs in oncology, neuroscience, immunology, and precision medicine, positioning spatial biology as a critical driver of next-generation diagnostics and therapeutics.

The field is experiencing rapid growth, powered by major market drivers such as rising investments in spatial transcriptomics for precision medicine, the growing importance of functional protein profiling in drug development, and the expanding use of retrospective tissue analysis for biomarker research. Opportunities are being unlocked through AI integration for scalable and predictive analysis and through continuous technological advancements in sequencing and imaging, enabling next-generation spatial biology platforms. However, market restraints such as high capital requirements, a shortage of skilled professionals, and technical limitations with FFPE sample compatibility continue to challenge broader adoption and scalability.

Leading players are shaping the competitive landscape through partnerships, acquisitions, and product innovations. For example, Bruker Corporation has aggressively expanded its spatial biology portfolio through the acquisition of NanoString's assets and the launch of its dedicated Spatial Biology Division, consolidating multi-omic platforms such as GeoMx and CosMx. Vizgen and Ultivue merged to deliver integrated spatial genomics and proteomics solutions, while Akoya Biosciences partnered with Thermo Fisher Scientific to commercialize combined RNA and protein spatial workflows. Startups like Stellaromics (USD 80M Series B) and RareCyte (USD 20M growth funding) are attracting strong venture backing to scale novel platforms like Pyxa and Orion. Meanwhile, 10x Genomics is expanding automation in single-cell and spatial workflows through its partnership with Hamilton Company, accelerating high-throughput studies.

Industry momentum is also marked by a shift toward antibody-independent spatial omics technologies and rising demand for high-throughput, discovery-driven platforms that enable multi-site reproducibility. With companies like Bio-Techne (launch of the COMET hyperplex multiomics system), Miltenyi Biotec (immune sequencing partnerships), and S2 Genomics (tissue dissociation workflow innovation) advancing product pipelines, the market is rapidly moving toward end-to-end solutions that unify sample prep, imaging, and multi-omics readouts.

In summary, the spatial biology market is positioning itself as a cornerstone of modern biomedical research and clinical translation, offering powerful, non-destructive tools to map the complexity of tissues with single-cell resolution. As investment, collaborations, and technology adoption accelerate, spatial biology is expected to significantly enhance biomarker discovery, drug development, and personalized medicine over the coming decade.

Industrial Impact

Spatial biology is transforming multiple sectors including drug discovery, clinical diagnostics, academic research, and biotechnology services. In drug development, it is accelerating biomarker discovery, target validation, and patient stratification by mapping molecular activity in tissues with high precision. In clinical and diagnostic settings, spatial technologies are reshaping oncology, immunology, and neuroscience by enabling accurate profiling of tumor microenvironments, immune cell interactions, and disease progression. Academic and translational researchers are applying spatial transcriptomics, proteomics, and metabolomics to uncover mechanisms in neurodegeneration, infectious diseases, and regenerative medicine, while biotechnology companies and CROs are integrating these tools into service offerings such as retrospective analysis of preserved tissues and high-plex imaging for clinical trials.

Impact: Together, these applications enhance precision medicine, improve diagnostic accuracy, accelerate translational breakthroughs, and reduce drug development risks-positioning spatial biology as a cornerstone technology for the future of biomedical research and healthcare innovation.

Market Segmentation:

Segmentation 1: By Molecular Technology

  • Spatial Transcriptomics/Genomics
  • Spatial Proteomics
  • Spatial Metabolomics
  • Spatial Multi-omics
  • Other Types

Spatial Transcriptomics/Genomics remains the leading segment by Molecular Technology in the global Spatial Biology market, holding an 41.15% market share in 2024, with a projected CAGR of 13.52% during the forecast period 2025-2035.

Spatial transcriptomics/genomics technology is emerging as a key driver in the growth of the spatial biology market, offering unprecedented insights into gene expression patterns within the spatial context of intact tissues. By combining RNA sequencing with spatial barcoding, in situ hybridization, and high-resolution microscopy, this technology allows researchers to map the molecular landscape of tissues at cellular resolution. Its applications in oncology, neuroscience, and developmental biology are expanding rapidly, as scientists seek to understand tissue heterogeneity, cellular interactions, and disease mechanisms more precisely. The increasing availability of user-friendly platforms, such as those from 10x Genomics and NanoString, along with growing interest in spatially resolved multi-omics, is accelerating adoption in both research and clinical settings. As the demand for precision medicine and targeted therapies rises, spatial transcriptomics is expected to play a central role in shaping the future of molecular diagnostics and drug development, contributing significantly to the overall expansion of the global spatial biology market.

Segmentation 2: By Product Type

  • Consumables
  • Instruments/Platforms
  • Service

Based on Product type, the global Spatial Biology market was led by Consumables segment, which accounted for a 41.64% market share in 2024. consumables is dominating the Spatial Biology market as it is a critical driver of recurring revenue and technological innovation in the global spatial biology market. These products are essential for preparing, labeling, and detecting molecular targets (RNA, proteins, metabolites) within intact tissue samples, forming the foundation of spatial workflows. Leading companies such as 10x Genomics, NanoString Technologies, and Akoya Biosciences have developed proprietary consumables that pair specifically with their spatial platforms. For instance, 10x Genomics offers spatial gene expression kits tailored to its Visium and Xenium platforms, enabling whole-transcriptome profiling with precise spatial mapping.

Segmentation 3: By Sample Type

  • FFPE (Formalin-Fixed, Paraffin-Embedded)
  • Fresh Frozen Tissue
  • Fixed Frozen

Based on sample type, the global Spatial Biology market was led by FFPE (Formalin-Fixed, Paraffin-Embedded), which accounted for a 44.68% share in 2024, making it the dominant and fastest-growing segment. FFPE is widely preferred due to its ability to preserve spatial context while enabling the analysis of gene, protein, and metabolite expression within tissues. Unlike traditional bulk sequencing or histology, spatial biology applied to FFPE allows high-resolution mapping of molecular activity directly within preserved tissue architecture, supporting earlier and more precise disease characterization. With advancements in platforms such as 10x Genomics' Visium and Xenium, NanoString's GeoMx DSP, and Akoya's PhenoCycler-Fusion, FFPE compatibility has expanded significantly, unlocking the potential of archived clinical samples and biobanks. As a result, its use is rapidly extending beyond oncology into neuroscience, immunology, and infectious diseases, solidifying FFPE as the most influential and high-growth sample type driving the spatial biology market forward..

Segmentation 4: By Application

  • Cancer Research
  • Immunology & Infectious Diseases
  • Neuroscience
  • Others

Based on application, the global Spatial Biology market is witnessing rapid expansion into emerging research areas, with research applications accounting for the largest share at 53.84% in 2024. While oncology, neurology, and immunology remain the established focus areas, research-led segments such as developmental biology, regenerative medicine, and toxicology are driving the next wave of growth. In developmental biology, spatial profiling enables mapping of cell differentiation and tissue patterning during embryogenesis, revealing gene expression gradients that guide organ formation. In regenerative medicine and organoid research, spatial techniques validate how engineered tissues replicate native structures and functions, ensuring accurate assessment before clinical translation. Similarly, in toxicology and pharmacokinetics, spatial biology allows precise tracking of drug distribution, local toxicity, and therapeutic response, strengthening safety and efficacy studies. By uncovering region-specific molecular signatures and novel biomarkers, research applications not only dominate the market today but also serve as the foundation for clinical translation. This strong research momentum, supported by multi-omics integration, positions spatial biology as a transformative enabler of next-generation life sciences and precision medicine.

Segmentation 5: By End Users

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutions
  • Contract Research Organizations (CROs)
  • Hospitals

Based on end-user, the global spatial biology market is witnessing strong expansion across pharmaceutical and biotechnology companies, academic and research institutions, contract research organizations (CROs), and hospitals. Among these, pharmaceutical and biotechnology companies account for the largest share at 45.37% in 2024, making them the dominant segment in the market. Their leadership is driven by the urgent need to accelerate drug discovery, optimize target validation, and identify novel biomarkers. Pharma and biotech players are investing heavily in spatial biology to obtain high-resolution insights into tissue heterogeneity, tumor microenvironments, and immune responses-critical factors for developing next-generation therapies and advancing precision medicine. This strong demand, coupled with significant R&D spending and rapid adoption of cutting-edge spatial technologies, positions the pharmaceutical and biotechnology segment as both the largest and the fastest-growing contributor to the market's expansion.

Segmentation 6: By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest-of-Europe
  • Asia-Pacific
    • Japan
    • India
    • China
    • Australia
    • Singapore
    • Rest-of-Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East and Africa
    • Egypt
    • Saudi Arabia
    • Rest of MEA

The Spatial Biology market in Europe is witnessing rapid expansion, driven by strong research funding, advanced healthcare infrastructure, and increasing adoption of multi-omics technologies across oncology, neurology, and immunology. The region benefits from well-established academic and research institutions, large biopharma clusters, and active participation in multi-country consortia that are accelerating translational and precision medicine initiatives. However, the market faces challenges such as high implementation costs and the need for specialized expertise to handle complex spatial datasets.

Within Europe, Germany holds the largest market share, supported by its strong pharmaceutical and biotechnology industry, significant government funding for life sciences, and a highly developed research ecosystem. The UK and France are also important contributors, actively adopting spatial transcriptomics and proteomics for drug development, biomarker discovery, and clinical applications. With these countries leading adoption, Europe is positioned as the fastest-growing region in the global Spatial Biology market, reflecting its strong commitment to innovation, collaboration, and integration of spatial biology into both research and healthcare settings.

Recent Developments in the Spatial Biology Market

  • May 2025 - Vizgen and Hamamatsu Photonics announced a strategic alliance to integrate multiplex immunofluorescence with Vizgen's InSituPlex(R) reagents and AI workflows, enhancing translational spatial proteomics.
  • Feb 2025 - Stellaromics closed an USD 80 million Series B funding round led by Catalyst4 and Stanford University Ventures to advance its 3D spatial biology platform, Pyxa.
  • Oct 2024 - Bruker launched its Spatial Biology Division, consolidating NanoString, Canopy, and Acuity platforms into a comprehensive spatial multi-omics portfolio.
  • May 2024 - Bruker completed the USD 392.6 million acquisition of NanoString's assets, including nCounter, GeoMx, CosMx, and AtoMx, strengthening its spatial transcriptomics and proteomics offering.
  • Nov 2024 - 10x Genomics partnered with Hamilton Company to automate single-cell workflows, enabling high-throughput processing of up to 96 samples per run.
  • Oct 2024 - Vizgen merged with Ultivue to combine MERFISH-based genomics with high-plex proteomics and AI imaging for end-to-end spatial multi-omics solutions.
  • Apr 2024 - Miltenyi Biotec partnered with MiLaboratories to co-develop RNA immune-sequencing kits with global commercialization rights.
  • Jan 2024 - Akoya Biosciences partnered with Thermo Fisher Scientific to launch an integrated spatial multi-omics workflow combining imaging and in situ hybridization.

Demand -Drivers, Challenges, and Opportunities

Market Demand Drivers:

  • Rising Investment Accelerating Adoption of Spatial Omics for Precision Medicine

The spatial biology market has been undergoing a transformative phase, driven by a surge in strategic investments, venture funding, and corporate acquisitions. As pharmaceutical companies, academic institutions, and diagnostic developers increasingly seek deeper insights into cellular architecture and tissue microenvironments, the demand for high-resolution spatial transcriptomics, proteomics, and multi-omics platforms has skyrocketed. In response, investors are backing companies with disruptive technologies that bridge the gap between molecular profiling and tissue context, crucial for advancing precision medicine, oncology research, and biomarker discovery. This influx of capital is not only fueling R&D pipelines but also enabling the commercialization and global scale-up of spatial platforms. Recent funding rounds and strategic investments reflect this momentum, with several key players securing support to enhance their technologies and expand market presence.

The substantial funding rounds and strategic transactions are catalyzing rapid technological advancement and market penetration. The investments have empowered companies to enhance throughput, automation, spatial resolution, and multimodal integration, making spatial biology more accessible and translationally relevant. As a result, the market is shifting from academic exploration toward clinical and pharmaceutical adoption. Moving forward, sustained financial support will remain essential for addressing workflow bottlenecks, standardizing analytical tools, and expanding compatibility with clinical sample types such as FFPE. With the foundation laid by these investments, spatial biology is well-positioned to become a cornerstone of next-generation diagnostics, drug development, and personalized medicine.

Some of the other factors creating an drivers for market growth include:

  • Advances in Spatial Biology for Preserved Tissue Samples

Note: All of the above factors will be evaluated in detail in the report.

Market Restraints:

  • Workforce Challenges in Spatial Biology Adoption

A major challenge limiting the adoption and scalability of spatial biology technologies is the shortage of skilled professionals capable of operating across this highly interdisciplinary space. Spatial biology demands proficiency in molecular biology, histology, imaging technologies, sequencing, and increasingly complex bioinformatics. However, most academic programs offer siloed training, lacking integration across wet-lab and computational disciplines. According to a 2024 CAP/AMP survey on workforce trends in molecular diagnostics labs (a comparable field in workflow complexity), labs reported an average of 4-5 open positions over two years, with 31% of those positions remaining unfilled, primarily due to the lack of adequately trained applicants. Moreover, the average time to hire technical staff was 16.5 weeks, contributing to substantial delays in data generation and analysis.

This workforce shortage is even more acute in the computational domain. As spatial platforms generate vast multimodal datasets (e.g., spatial transcriptomics, spatial proteomics, imaging mass cytometry), researchers increasingly require expertise in machine learning, spatial statistics, and high-dimensional data integration. Yet, talent trained at the intersection of biology and data science remains scarce. A recent review in Immunology & Cell Biology emphasized that standardized bioinformatics pipelines and skilled analysts are essential for translating raw spatial data into meaningful biological insights, yet these are often missing from many labs.

Note: All of the above factors will be evaluated in detail in the report.

Market Opportunities: AI Bridging the Gap Between Routine Pathology and Spatial Omics

Advances in artificial intelligence are rapidly transforming spatial biology by enabling scalable, predictive, and more cost-effective deployment of spatial omics technologies. A key example is Path2Space, a deep learning model trained on spatial transcriptomics datasets, capable of predicting spatial gene expression directly from standard histopathology (H&E) slides. By effectively bypassing expensive spatial capture assays, Path2Space can potentially impact over 20 million histology samples processed annually in diagnostic labs, unlocking spatial insights at minimal incremental cost. Such models promise to democratize spatial omics by reducing dependence on expensive instrumentation and consumables, accelerating biomarker discovery and disease mapping at scale. The integration of artificial intelligence into spatial biology is transforming the field from a data-intensive research tool into a high-throughput, clinically applicable platform. This shift is opening significant commercial opportunities across drug development, precision diagnostics, and biomarker discovery. One of the most notable developments illustrating this trend is the March 2024 merger between Vizgen and Ultivue, aimed at building a next-generation AI-powered spatial multi-omics platform. They have announced a strategic merger to create a powerful, AI-enabled spatial multi-omics platform. This collaboration was driven by the growing need for integrated biological insights that span both gene expression and protein localization, critical for understanding complex disease mechanisms, particularly in oncology and immunology.

Some of the other factors creating an opportunity for market growth include:

  • Technological Advancements and Technology and Partnerships Boosting Spatial Biology

Note: All of the above factors will be evaluated in detail in the report.

Market Trends:

  • Surge in Demand for High-Throughput and Discovery-Driven Platforms

The spatial biology market has been undergoing a significant evolution, marked by a growing industrial trend toward high-throughput, discovery-driven platforms that offer scalable and multiplexed molecular profiling. This demand stems from the need to analyze increasingly complex tissue samples in research and clinical settings, where understanding the spatial organization of cells and their molecular signatures is crucial for uncovering disease mechanisms, identifying novel biomarkers, and advancing precision medicine.

These developments reflect a fundamental shift from hypothesis-driven to discovery-oriented research workflows, empowering scientists to uncover previously inaccessible insights in oncology, neuroscience, immunology, and developmental biology. The ability to handle multiple samples, integrate multi-omics layers, and work with clinically relevant tissue formats such as FFPE makes these platforms central to modern spatial research. As multi-omics, AI-driven analytics, and cloud-based workflow integration further evolve, discovery-centric spatial platforms will not only accelerate scientific insights but also play a critical role in the evolution of personalized medicine and next-generation therapeutics.

Note: All of the above trends will be evaluated in detail in the report.

How can this report add value to an organization?

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements in Spatial Biology, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses in Spatial Biology and allowing them to strategize effectively to gain a competitive edge in the market.

Regulatory and Compliance Strategy: It provides updates on evolving regulatory frameworks, approvals, and industry guidelines specific to Spatial Biology, ensuring organizations stay compliant and accelerate market entry for new Spatial Biology

Investment and Business Expansion Strategy: By analyzing market trends, funding patterns, and partnership opportunities, the report assists organizations in making informed investment decisions and identifying potential M&A opportunities for business growth.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the market size is 2024. A historical year analysis has been done for the period FY2023. The market size has been estimated for FY2024 and projected for the period FY2025-FY2035.
  • The scope of this report has been carefully derived based on extensive interactions with experts and stakeholders across leading companies and research institutions worldwide. This report provides a comprehensive market analysis of robotics and non-robotics within the Spatial Biology market.
  • Revenues of the companies have been referenced from their annual reports for FY2023 and FY2024. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
  • The market has been mapped based on the available Spatial Biology products. All the key companies with significant offerings in this field have been considered and profiled in this report.

Primary Research:

The primary sources involve industry experts in Spatial Biology, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • Validation and triangulation of all the numbers and graphs
  • Validation of the report's segmentation and key qualitative findings
  • Understanding the competitive landscape and business model
  • Current and proposed production values of a product by market players
  • Validation of the numbers of the different segments of the market in focus
  • Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • Segmentations and percentage shares
  • Data for market value
  • Key industry trends of the top players of the market
  • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts, as well as analyzing company coverage, product portfolio, and market penetration.

The Spatial Biology market encompasses a wide range of technologies designed to map and analyze molecular activity within tissues while preserving spatial context. From spatial transcriptomics and proteomics to metabolomics and multi-omics integration, these approaches are unlocking new dimensions in understanding disease mechanisms and cellular interactions. As advancements in high-plex imaging, sequencing, and bioinformatics continue, this market is set to grow rapidly, impacting fields such as oncology, immunology, neuroscience, and infectious disease research. With a growing focus on precision medicine, biomarker discovery, and translational applications, spatial biology technologies are becoming a critical part of modern biomedical research, with a particularly strong future in cancer research, drug development, and personalized healthcare.

Some prominent names established in this market are:

  • Akoya Biosciences, Inc.
  • 10x Genomics
  • Bio-Techne
  • Standard BioTools
  • Bruker Corporation
  • Illumina, Inc.

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

  • 1.1 Key Market Trends
    • 1.1.1 Impact Analysis
  • 1.2 Surge in Demand for High-Throughput and Discovery-Driven Platforms
  • 1.3 Shift toward Antibody-Independent Spatial Omics Technologies
  • 1.4 Regulatory Framework
    • 1.4.1 U.S.
      • 1.4.1.1 Regulatory Requirements for Products Intended as Medical Devices
      • 1.4.1.2 Regulatory Requirements for Research Use Only (RUO) Products
    • 1.4.2 European Union (EU)
      • 1.4.2.1 Regulatory Requirements for Products Intended as Medical Devices
        • 1.4.2.1.1 EU Medical Device Regulation
        • 1.4.2.1.2 EU In Vitro Diagnostic Regulation
      • 1.4.2.2 Regulatory Requirements for Sequencing Labs in the EU
    • 1.4.3 Japan
      • 1.4.3.1 Regulatory Requirements for Products Intended as Medical Devices
      • 1.4.3.2 Regulatory Requirements in Japan
    • 1.4.4 China
      • 1.4.4.1 Regulatory Requirements for Products Intended as Medical Devices
  • 1.5 Supply Chain Analysis
  • 1.6 Market Dynamics
    • 1.6.1 Market Drivers
      • 1.6.1.1 Rising Investment Accelerating Adoption of Spatial Omics for Precision Medicine
      • 1.6.1.2 Advances in Spatial Proteomics for Drug Discovery
      • 1.6.1.3 Advances in Spatial Biology for Preserved Tissue Samples
    • 1.6.2 Market Restraints
      • 1.6.2.1 Workforce Challenges in Spatial Biology Adoption
      • 1.6.2.2 Ongoing Challenges in Using FFPE Tissues for Spatial Biology
    • 1.6.3 Market Opportunities
      • 1.6.3.1 AI Bridging the Gap Between Routine Pathology and Spatial Omics
      • 1.6.3.2 Technological Advancements and Technology and Partnerships Boosting Spatial Biology

2 By MolecularTechnology

  • 2.1 By Molecular Technology
    • 2.1.1 Overview
  • 2.2 Spatial Transcriptomics/Genomics
    • 2.2.1 Sequencing-Based Spatial Transcriptomics
    • 2.2.2 In Situ Hybridization (ISH)
    • 2.2.3 In Situ Sequencing (ISS)
    • 2.2.4 Other Spatial Transcriptomics/Genomics technologies
  • 2.3 Spatial Proteomics
    • 2.3.1 Antibody-Based Multiplex Imaging
    • 2.3.2 MALDI-MS Imaging
    • 2.3.3 In Situ Sequencing (CITE-seq)
    • 2.3.4 Deep Visualization Proteomics (DVP)
    • 2.3.5 Other Spatial Proteomics Technologies
  • 2.4 Spatial Metabolomics
    • 2.4.1 MALDI Mass Spectrometry Imaging (MALDI-MSI)
    • 2.4.2 Desorption Electrospray Ionization (DESI) and Nano-DESI Imaging
  • 2.5 Spatial Multi-omics
  • 2.6 Other Molecular Technologies

3 By Product

  • 3.1 By Product
    • 3.1.1 Overview
    • 3.1.2 Consumables
    • 3.1.3 Instruments/Platforms
    • 3.1.4 Services

4 By Sample Type

  • 4.1 By Sample Type
    • 4.1.1 Overview
    • 4.1.2 Formalin-Fixed, Paraffin-Embedded (FFPE)
    • 4.1.3 Fresh Frozen Tissue
    • 4.1.4 Fixed Frozen Tissue

5 By Application

  • 5.1 By Application
    • 5.1.1 Overview
    • 5.1.2 Cancer Research
    • 5.1.3 Immunology and Infectious Diseases
    • 5.1.4 Neuroscience
    • 5.1.5 Others

6 By End-User

  • 6.1 By End User
    • 6.1.1 Overview
    • 6.1.2 Pharmaceutical and Biotechnology Companies
    • 6.1.3 Academic and Research Institutions
    • 6.1.4 Contract Research Organizations (CROs)
    • 6.1.5 Hospitals

7 Region

  • 7.1 Regional Summary
  • 7.2 North America
    • 7.2.1 Regional Overview
    • 7.2.2 Driving Factors for Market Growth
    • 7.2.3 Factors Challenging the Market
    • 7.2.4 Analyst View
      • 7.2.4.1 North America Spatial Biology Market, $Million, 2023-2035
    • 7.2.5 U.S.
      • 7.2.5.1 U.S. Spatial Biology Market, $Million, 2023-2035
    • 7.2.6 Canada
      • 7.2.6.1 Canada Spatial Biology Market, $Million, 2023-2035
  • 7.3 Europe
    • 7.3.1 Regional Overview
    • 7.3.2 Driving Factors for Market Growth
    • 7.3.3 Factors Challenging the Market
    • 7.3.4 Analyst View
    • 7.3.5 Germany
    • 7.3.6 France
    • 7.3.7 Italy
    • 7.3.8 Spain
    • 7.3.9 U.K.
    • 7.3.10 Rest-of-Europe
  • 7.4 Asia-Pacific
    • 7.4.1 Regional Overview
    • 7.4.2 Driving Factors for Market Growth
    • 7.4.3 Factors Challenging the Market
    • 7.4.4 Analyst View
      • 7.4.4.1 Asia-Pacific Spatial Biology Market, $Million, 2023-2035
    • 7.4.5 China
    • 7.4.6 Japan
    • 7.4.7 India
    • 7.4.8 Singapore
    • 7.4.9 Australia
    • 7.4.10 Rest-of-Asia-Pacific
  • 7.5 Latin America
    • 7.5.1 Regional Overview
    • 7.5.2 Driving Factors for Market Growth
    • 7.5.3 Factors Challenging the Market
    • 7.5.4 Analyst View
    • 7.5.5 Brazil
    • 7.5.6 Mexico
    • 7.5.7 Rest-of-Latin America
  • 7.6 Middle East and Africa
    • 7.6.1 Regional Overview
    • 7.6.2 Driving Factors for Market Growth
    • 7.6.3 Factors Challenging the Market
    • 7.6.4 Analyst View
    • 7.6.5 Egypt
    • 7.6.6 Saudi Arabia
    • 7.6.7 Rest-of-the-Middle East and Africa

8 Markets - Competitive Benchmarking & Company Profiles

  • 8.1 Akoya Biosciences, Inc.
    • 8.1.1 Top Products/Product Portfolio
    • 8.1.2 Competitors
    • 8.1.3 Target Customers
    • 8.1.4 Strategic Positioning and Market Impact
    • 8.1.5 Analyst View
    • 8.1.6 Pipeline and Research Initiatives
  • 8.2 10x Genomics
    • 8.2.1 Overview
    • 8.2.2 Top Products/Product Portfolio
    • 8.2.3 Top Competitors
    • 8.2.4 Strategic Positioning and Market Impact
    • 8.2.5 Key Personal
    • 8.2.6 Analyst View
    • 8.2.7 Research Initiatives
  • 8.3 Standard BioTools
    • 8.3.1 Overview
    • 8.3.2 Top Products/Product Portfolio
    • 8.3.3 Top Competitors
    • 8.3.4 Target Customers
    • 8.3.5 Strategic Positioning and Market Impact
    • 8.3.6 Analyst View
    • 8.3.7 Research Initiatives
  • 8.4 Bio-Techne
    • 8.4.1 Overview
    • 8.4.2 Top Products/Product Portfolio
    • 8.4.3 Top Competitors
    • 8.4.4 Target Customers
    • 8.4.5 Strategic Positioning and Market Impact
    • 8.4.6 Analyst View
    • 8.4.7 Research Initiatives
  • 8.5 Illumina, Inc.
    • 8.5.1 Overview
    • 8.5.2 Top Products/Product Portfolio
    • 8.5.3 Top Competitors
    • 8.5.4 Target Customers
    • 8.5.5 Strategic Positioning and Market Impact
    • 8.5.6 Analyst View
    • 8.5.7 Pipeline and Research Initiatives
  • 8.6 Bruker Corporation
    • 8.6.1 Overview
    • 8.6.2 Top Products/Product Portfolio
    • 8.6.3 Top Competitors
    • 8.6.4 Target Customers
    • 8.6.5 Strategic Positioning and Market Impact
    • 8.6.6 Analyst View
    • 8.6.7 Pipeline and Research Initiatives
  • 8.7 Flagship Biosciences, Inc.
    • 8.7.1 Overview
    • 8.7.2 Top Products/Product Portfolio
    • 8.7.3 Top Competitors
    • 8.7.4 Target Customers
    • 8.7.5 Strategic Positioning and Market Impact
    • 8.7.6 Analyst View
    • 8.7.7 Pipeline and Research Initiatives
  • 8.8 S2 Genomics, Inc.
    • 8.8.1 Overview
    • 8.8.2 Top Products/Product Portfolio
    • 8.8.3 Top Competitors
    • 8.8.4 Target Customers
    • 8.8.5 Strategic Positioning and Market Impact
    • 8.8.6 Analyst View
    • 8.8.7 Pipeline and Research Initiative
  • 8.9 MGI Tech Co., Ltd.
    • 8.9.1 Overview
    • 8.9.2 Top Products/Product Portfolio
    • 8.9.3 Top Competitors
    • 8.9.4 Target Customers
    • 8.9.5 Strategic Positioning and Market Impact
    • 8.9.6 Analyst View
    • 8.9.7 Research Initiatives
  • 8.1 Vizgen Inc.
    • 8.10.1 Overview
    • 8.10.2 Top Products/Product Portfolio
    • 8.10.3 Top Competitors
    • 8.10.4 Target Customers
    • 8.10.5 Strategic Positioning and Market Impact
    • 8.10.6 Analyst View
    • 8.10.7 Research Initiatives
  • 8.11 RareCyte, Inc.
    • 8.11.1 Overview
    • 8.11.2 Top Products/Product Portfolio
    • 8.11.3 Top Competitors
    • 8.11.4 Target Customers
    • 8.11.5 Strategic Positioning and Market Impact
    • 8.11.6 Analyst View
    • 8.11.7 Research Initiatives
  • 8.12 Miltenyi Biotec
    • 8.12.1 Overview
    • 8.12.2 Top Products/Product Portfolio
    • 8.12.3 Top Competitors
    • 8.12.4 Target Customers
    • 8.12.5 Strategic Positioning and Market Impact
    • 8.12.6 Analyst View
    • 8.12.7 Research Initiatives
  • 8.13 Spatial Genomics
    • 8.13.1 Overview
    • 8.13.2 Top Products/Product Portfolio
    • 8.13.3 Top Competitors
    • 8.13.4 Target Customers
    • 8.13.5 Strategic Positioning and Market Impact
    • 8.13.6 Analyst View
    • 8.13.7 Research Initiatives
  • 8.14 Singular Genomics
    • 8.14.1 Overview
    • 8.14.2 Top Products/Product Portfolio
    • 8.14.3 Top Competitors
    • 8.14.4 Target Customers
    • 8.14.5 Strategic Positioning and Market Impact
    • 8.14.6 Analyst View
    • 8.14.7 Research Initiatives
  • 8.15 Stellaromics
    • 8.15.1 Overview
    • 8.15.2 Top Products/Product Portfolio
    • 8.15.3 Top Competitors
    • 8.15.4 Target Customers
    • 8.15.5 Strategic Positioning and Market Impact
    • 8.15.6 Analyst View
    • 8.15.7 Research Initiatives

9 Research Methodology

  • 9.1 Data Sources
    • 9.1.1 Primary Data Sources
    • 9.1.2 Secondary Data Sources
    • 9.1.3 Inclusion and Exclusion
    • 9.1.4 Data Triangulation
  • 9.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Spatial Biology Market (by Scenario), $Million, 2024, 2028, and 2035
  • Figure 2: Top 10 Countries, Global Spatial Biology Market, $Million, 2024
  • Figure 3: Global Spatial Biology Market Snapshot
  • Figure 4: Global Spatial Biology Market, $Million, 2024 and 2035
  • Figure 5: Global Spatial Biology Market (by Molecular Technology Type), $Million, 2024, 2028, and 2035
  • Figure 6: Global Spatial Biology Market (by Product Type), $Million, 2024, 2028, and 2035
  • Figure 7: Global Spatial Biology Market (by Sample Type), $Million, 2024, 2028, and 2035
  • Figure 8: Global Spatial Biology Market (by Application), $Million, 2024, 2028, and 2035
  • Figure 9: Global Spatial Biology Market (by End User), $Million, 2024, 2028, and 2035
  • Figure 10: Global Spatial Biology Market Segmentation
  • Figure 11: Supply Chain Analysis: Global Spatial Biology Market
  • Figure 12: Global Spatial Biology Market, by Molecular Technology, $Million, 2024, 2028, and 2035
  • Figure 13: Global Spatial Biology Market, by Spatial Transcriptomics/Genomics, $Million, 2023-2035
  • Figure 14: Global Spatial Biology Market, by Sequencing-Based Spatial Transcriptomics, $Million, 2023-2035
  • Figure 15: Global Spatial Biology Market, by In Situ Hybridization (ISH), $Million, 2023-2035
  • Figure 16: Global Spatial Biology Market, by In Situ Sequencing (ISS), $Million, 2023-2035
  • Figure 17: Global Spatial Biology Market, by Other Spatial Transcriptomics/Genomics technologies, $Million, 2023-2035
  • Figure 18: Global Spatial Biology Market, by Spatial Proteomics, $Million, 2023-2035
  • Figure 19: Global Spatial Biology Market, by Antibody-Based Multiplex Imaging, $Million, 2023-2035
  • Figure 20: Global Spatial Biology Market, by MALDI-MS Imaging, $Million, 2023-2035
  • Figure 21: Global Spatial Biology Market, by In Situ Sequencing (CITE-seq), $Million, 2023-2035
  • Figure 22: Global Spatial Biology Market, by Deep Visualization Proteomics (DVP), $Million, 2023-2035
  • Figure 23: Global Spatial Biology Market, by Other Spatial Proteomics Technologies, $Million, 2023-2035
  • Figure 24: Global Spatial Biology Market, by Spatial Metabolomics, $Million, 2023-2035
  • Figure 25: Global Spatial Biology Market, by MALDI Mass Spectrometry Imaging (MALDI-MSI), $Million, 2023-2035
  • Figure 26: Global Spatial Biology Market, by Desorption Electrospray Ionization (DESI) and Nano-DESI Imaging, $Million, 2023-2035
  • Figure 27: Global Spatial Biology Market, by Spatial Multi-Omics, $Million, 2023-2035
  • Figure 28: Global Spatial Biology Market, by Other Molecular Technologies, $Million, 2023-2035
  • Figure 29: Global Spatial Biology Market, by Product, $Million, 2024, 2028, and 2035
  • Figure 30: Global Spatial Biology Market, by Consumables, $Million, 2023-2035
  • Figure 31: Global Spatial Biology Market, by Instruments/Platforms, $Million, 2023-2035
  • Figure 32: Global Spatial Biology Market, by Services, $Million, 2023-2035
  • Figure 33: Global Spatial Biology Market, by Sample Type, $Million, 2024, 2028, and 2035
  • Figure 34: Global Spatial Biology Market, by Formalin-Fixed, Paraffin-Embedded (FFPE), $Million, 2023-2035
  • Figure 35: Global Spatial Biology Market, by Fresh Frozen Tissue, $Million, 2023-2035
  • Figure 36: Global Spatial Biology Market, by Fixed Frozen Tissue, $Million, 2023-2035
  • Figure 37: Global Spatial Biology Market, by Application, $Million, 2024, 2028, and 2035
  • Figure 38: Global Spatial Biology Market, by Cancer Research, $Million, 2023-2035
  • Figure 39: Global Spatial Biology Market, by Immunology and Infectious Diseases, $Million, 2023-2035
  • Figure 40: Global Spatial Biology Market, by Neuroscience, $Million, 2023-2035
  • Figure 41: Global Spatial Biology Market, by Others, $Million, 2023-2035
  • Figure 42: Global Spatial Biology Market, by End User, $Million, 2024, 2028, and 2035
  • Figure 43: Global Spatial Biology Market, by Pharmaceutical and Biotechnology Companies, $Million, 2023-2035
  • Figure 44: Global Spatial Biology Market, by Academic and Research Institutions, $Million, 2023-2035
  • Figure 45: Global Spatial Biology Market, by Contract Research Organizations (CROs), $Million, 2023-2035
  • Figure 46: Global Spatial Biology Market, by Hospitals, $Million, 2023-2035
  • Figure 47: Europe Spatial Biology Market, $Million, 2023-2035
  • Figure 48: Germany Spatial Biology Market, $Million, 2023-2035
  • Figure 49: France Spatial Biology Market, $Million, 2023-2035
  • Figure 50: Italy Spatial Biology Market, $Million, 2023-2035
  • Figure 51: Spain Spatial Biology Market, $Million, 2023-2035
  • Figure 52: U.K. Spatial Biology Market, $Million, 2023-2035
  • Figure 53: Rest-of-Europe Spatial Biology Market, $Million, 2023-2035
  • Figure 54: China Spatial Biology Market, $Million, 2023-2035
  • Figure 55: Japan Spatial Biology Market, $Million, 2023-2035
  • Figure 56: India Spatial Biology Market, $Million, 2023-2035
  • Figure 57: Singapore Spatial Biology Market, $Million, 2023-2035
  • Figure 58: Australia Spatial Biology Market, $Million, 2023-2035
  • Figure 59: Rest-of-Asia-Pacific Spatial Biology Market, $Million, 2023-2035
  • Figure 60: Latin America Spatial Biology Market, $Million, 2023-2035
  • Figure 61: Brazil Spatial Biology Market, $Million, 2023-2035
  • Figure 62: Mexico Spatial Biology Market, $Million, 2023-2035
  • Figure 63: Rest-of-Latin America Spatial Biology Market, $Million, 2023-2035
  • Figure 64: Middle East and Africa Spatial Biology Market, $Million, 2023-2035
  • Figure 65: Egypt Spatial Biology Market, $Million, 2023-2035
  • Figure 66: Saudi Arabia Spatial Biology Market, $Million, 2023-2035
  • Figure 67: Rest-of-the-MEA Spatial Biology Market, $Million, 2023-2035
  • Figure 68: Inclusion and Exclusion for the Global Spatial Biology Market
  • Figure 69: Data Triangulation
  • Figure 70: Top-Down and Bottom-Up Approach
  • Figure 71: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Global Spatial Biology Market, 2024 and 2035
  • Table 3: Key Market Trends
  • Table 4: Market Dynamics
  • Table 5: Key Investments Accelerating the Global Spatial Biology Market
  • Table 6: Key Developments Driving Innovation in Drug Development
  • Table 7: Transformative Collaborations and Technology Advancements in Spatial Biology
  • Table 8: Global Spatial Biology Market (by Region), $Million, 2023-2035
  • Table 9: North America Spatial Biology Market (by Country), $Million, 2023-2035
  • Table 10: Europe Spatial Biology Market (by Country), $Million, 2023-2035
  • Table 11: Asia-Pacific Spatial Biology Market (by Country), $Million, 2023-2035
  • Table 12: Latin America Spatial Biology Market (by Country), $Million, 2023-2035
  • Table 13: Middle East and Africa Spatial Biology Market (by Country), $Million, 2023-2035